ENDPOINTS

Insmed’s stock rallies on PAH data; Unicycive aims to resolve CDMO issues

Plus, news about AriBio, Arcera, Molecular Partners, Valneva, MacroGenics, Sagard Healthcare Partners, Quell Therapeutics, AstraZeneca, Guardian Bio, Lucy Therapeutics, Argenica, and Gilead’s Tmunity: Insmed’s stock jumps on PAH data: In Phase 2 results, Insmed ...

Jun 10, 2025 - 15:50
 0
Insmed’s stock rallies on PAH data; Unicycive aims to resolve CDMO issues
Plus, news about AriBio, Arcera, Molecular Partners, Valneva, MacroGenics, Sagard Healthcare Partners, Quell Therapeutics, AstraZeneca, Guardian Bio, Lucy Therapeutics, Argenica, and Gilead’s Tmunity: Insmed’s stock jumps on PAH data: In Phase 2 results, Insmed ...
Read More

Tags:

Previous Article

Carbon nanotubes replace metal coils for ultra-lightweight electric motors

Next Article

NASA Student Challenge Prepares Future Designers for Lunar Missions

Related Posts

Eli Lilly teams up with RNA editing biotech for hearing loss

Eli Lilly teams up with RNA editing biotech for hearing...

May 15, 2025  0

Laid-off FDA workers wait in limbo, collecting pay and wondering what's next

Laid-off FDA workers wait in limbo, collecting pay and ...

Jun 2, 2025  0

RFK Jr. defends HHS staff cuts at two congressional hearings

RFK Jr. defends HHS staff cuts at two congressional hea...

May 14, 2025  0